(Q34278990)

1 August 2017

Age-dependent synuclein pathology following traumatic brain injury in mice (English)

1 reference

1 August 2017

traumatic brain injury

0 references

0 references

1 reference

K Uryu

1

1 reference

1 August 2017

B I Giasson

2

1 reference

1 August 2017

L Longhi

3

1 reference

1 August 2017

D Martinez

4

1 reference

1 August 2017

I Murray

5

1 reference

1 August 2017

V Conte

6

1 reference

1 August 2017

M Nakamura

7

1 reference

1 August 2017

K Saatman

8

1 reference

1 August 2017

K Talbot

9

1 reference

1 August 2017

T Horiguchi

10

1 reference

1 August 2017

T McIntosh

11

1 reference

1 August 2017

V M-Y Lee

12

1 reference

1 August 2017

J Q Trojanowski

13

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

1 August 2017

Experimental Neurology

1 reference

1 August 2017

184

1 reference

1 August 2017

1

1 reference

1 August 2017

214-224

1 reference

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Staging of brain pathology related to sporadic Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Upregulation of nerve growth factor following cortical trauma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Prior history of head trauma in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

A Drosophila model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

alpha-Synuclein is phosphorylated in synucleinopathy lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Prominent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Risk factors for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

The association between neuronal nitric oxide synthase and neuronal sensitivity in the brain after brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

A mechanistic analysis of nondisruptive axonal injury: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

The Dorothy Russell Memorial Lecture. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Reduction of tyrosine nitration after N(omega)-nitro-L-arginine-methylester treatment of mice with traumatic brain injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Twofold overexpression of human beta-amyloid precursor proteins in transgenic mice does not affect the neuromotor, cognitive, or neurodegenerative sequelae following experimental brain injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Brain trauma in aged transgenic mice induces regression of established abeta deposits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Induction of alpha-synuclein aggregation by intracellular nitrative insult.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Enduring cognitive, neurobehavioral and histopathological changes persist for up to one year following severe experimental brain injury in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Local and systemic increase in lipid peroxidation after moderate experimental traumatic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Double immunolabeling of neuropeptides in the human hypothalamus as analyzed by confocal laser scanning fluorescence microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Chaperone-like activity of synucleins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Alpha-synuclein in Lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Synuclein-1 is selectively up-regulated in response to nerve growth factor treatment in PC12 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Head trauma as a risk factor for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Environmental factors and Parkinson's disease: a case-control study in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Parkinson disease in twins: an etiologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900245-0

10.1016/S0014-4886(03)00245-0

7 January 2021

Identifiers

DOI

1 reference

1 August 2017

1 reference